Copertina

Comprehensive intervention combining group and personalized language therapy in primary progressive aphasia: Quantitative and qualitative findings

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Tijana Simic, Laura Laird, Rudra Patel, Monica Lavoie, Maria Martinez, Paula Gosse, Alexandra Santos, David Tang‐Wai, Regina Jokel, Carmela Tartaglia, Elizabeth Rochon
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Cognitive training, alone and combined with acetylcholinesterase inhibitors, in neurocognitive disorders: long‐term efficacy and the role of cognitive reserve on 30 months of intervention
di: Adele Ravelli, et al.
Pubblicazione: (2026)

Development and classification accuracy of an automated cognitive screening tool combining working memory and connected speech tasks for early detection of cognitive impairment in primary care
di: Robin C. Hilsabeck, et al.
Pubblicazione: (2025)

Site‐level factors affecting nursing home implementation of a personalized music intervention: Qualitative analyses from Music & Memory: A Pragmatic Trial for Nursing Home Residents with Alzheimer's Disease (METRIcAL)
di: Davoodi Natalie, et al.
Pubblicazione: (2024)

Cost‐effectiveness of a multicomponent intervention against cognitive decline
di: Christian Brettschneider, et al.
Pubblicazione: (2025)

Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions
di: Jamie L. Hamilton, et al.
Pubblicazione: (2025)

Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
di: Krista Lanctot, et al.
Pubblicazione: (2025)

The utility of a composite endpoint for tracking disease progression in Lewy body dementia
di: Elie Matar, et al.
Pubblicazione: (2026)

Characterizing clinician communication with patients about lecanemab: A qualitative study of clinicians across seven academic medical centers
di: Anna L. Parks, et al.
Pubblicazione: (2025)

Two new positive psychosocial measures for persons living with dementia
di: Sheila L. Molony, et al.
Pubblicazione: (2025)

A mindfulness‐based multicomponent caregiver intervention (PAACC): objectives, study design, and cohort description
di: Mamta Sapra, et al.
Pubblicazione: (2025)

Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment
di: Takuya Ataka, et al.
Pubblicazione: (2024)

Building digital solutions to support brain health prescribing in primary care: Where to begin?
di: Joyce Siette, et al.
Pubblicazione: (2024)

Effects of care partner type on outcomes from a multicomponent behavioral intervention for mild cognitive impairment
di: Zhigang Xie, et al.
Pubblicazione: (2026)

Correction to “Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study”
Pubblicazione: (2026)

Weight loss and metabolic improvements dominate the microbiome response in the MIND diet intervention: a randomized controlled trial
di: Robin M. Voigt, et al.
Pubblicazione: (2026)

Mapping brain change longitudinally: physical activity intervention reshapes structural alterations and functional connectivity in Alzheimer's disease
di: Ravi Dadsena, et al.
Pubblicazione: (2026)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
di: Ronald C. Petersen, et al.
Pubblicazione: (2025)

Effects of multidomain intervention on cognitive function in older adults with cognitive impairment: A multicenter, four‐arm, cluster randomized trial
di: Zhaoxue Yin, et al.
Pubblicazione: (2026)

Electroencephalography‐based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high‐risk for progression to dementia
di: Chiara Pappalettera, et al.
Pubblicazione: (2025)

Constructive engagement in cognitive stimulation therapy groups among people with dementia: A mixed‐methods study
di: Anna Yan Zhang, et al.
Pubblicazione: (2025)

Erratum to “Evaluation of efficiency and effectiveness of different recruitment strategies for the FINGER‐NL multidomain lifestyle intervention trial via the Dutch Brain Research Registry”
Pubblicazione: (2025)

Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease–related cognitive decline
di: Yuan Shang, et al.
Pubblicazione: (2025)

Blood‐based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost‐effectiveness in Alzheimer's disease prevention studies
di: Kenichiro Sato, et al.
Pubblicazione: (2025)

The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non‐carriers with mild cognitive impairment due to Alzheimer's disease
di: Arnold Bakker, et al.
Pubblicazione: (2024)

Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies
di: Xiaojuan Li, et al.
Pubblicazione: (2025)

Lifestyle medicine and brain health: Insights from the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) and the promise of personalization
di: Alfonso Alfini, et al.
Pubblicazione: (2025)

Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof‐of‐principle study and call to action
di: Mark A. Dubbelman, et al.
Pubblicazione: (2024)

Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective
di: Khushbu J. Patel, et al.
Pubblicazione: (2024)

Lower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
di: Bernadette A. Fausto, et al.
Pubblicazione: (2026)

Profiling the needs of dementia caregivers in a Brazilian cross‐sectional study
di: Alan Cronemberger Andrade, et al.
Pubblicazione: (2025)

Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
di: Luke E. Stoeckel, et al.
Pubblicazione: (2025)

Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
di: Chao‐Yi Wu, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)

Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
di: Jeffrey Cummings
Pubblicazione: (2025)

Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late‐onset Alzheimer's disease in an urban Latino population
di: John B. Wetmore, et al.
Pubblicazione: (2024)

Diabetes mellitus exacerbates changes in white matter hyperintensity shapes and volume: A longitudinal study
di: Shihao Xu, et al.
Pubblicazione: (2025)

Assessing social connection for long‐term care home residents: A scoping review of measure content
di: Madalena P. Liougas, et al.
Pubblicazione: (2024)

The African Initiative for Bioinformatics Online Training in Neurodegenerative Diseases (AI‐BOND): Investing in the next generation of African neuroscientists
di: Bernard Fongang, et al.
Pubblicazione: (2024)

Cardiorespiratory fitness modifies the relationship between arterial stiffness and cerebral blood flow independent of physical activity
di: Brianne M. Breidenbach, et al.
Pubblicazione: (2025)

The functional role of the pulvinar in discriminating between objective and subjective cognitive impairment in major depressive disorder
di: Burak Yulug, et al.
Pubblicazione: (2024)